Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10305127 | Psychiatry Research | 2005 | 7 Pages |
Abstract
Knowledge of what constitutes a minimal clinically important difference and change on a psychiatric rating scale is essential in interpreting its scores. The present study examines the Beck Depression Inventory-II (BDI-II), a recently revised successor to the world's most popular self-rating instrument for depression. BDI-II was administered to 85 patients with major depression, diagnosed with DSM-IV along with its severity specifiers. It was again administered to 40 first-visit patients from the original sample when they returned 14 or more days later. The Clinical Global Impression-Change Scale was rated at the same time. All the ratings were done independent of each other. The BDI-II was able to distinguish between all grades of depression severity. An approximate 10-point difference existed between each severity specifier. The BDI-II was also sensitive to change in depression: a 5-point difference corresponded to a minimally important clinical difference, 10-19 points to a moderate difference, and 20 or more points to a large difference. Given the already established high reliability, content validity, construct validity and factorial validity, and the high sensitivity to between-subject differences and within-subject changes demonstrated in the present study, the BDI-II promises to continue to be a leading self-rating instrument to assess depression severity worldwide.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Takahiro Hiroe, Masayo Kojima, Ikuyo Yamamoto, Suguru Nojima, Yoshihiro Kinoshita, Nobuhiko Hashimoto, Norio Watanabe, Takao Maeda, Toshi A. Furukawa,